Smoking in United States of America
In the United States of America, smoking is allowed but tobacco products should follow some regulations. Under these regulations, health warnings on tobacco packaging including cigarettes are mandatory, the minimum legal age for their sales is 21 years, and there are no federal legal restrictions on smoking in public places. While tobacco advertising is regulated, not all forms of their advertising are banned. An excise tax of 32.16% with a total taxation rate of 37.36% is applied on cigarettes. Cigarettes can legally be sold with authorised documents. They may also be purchased through vending machines as well as through online channels. Importing cigarettes for trade is allowed with an appropriate import license. Despite these control measures, prevalence data show that smoking remains an important public health issue in the United States. There were 39.8 million current smokers in the country in 2024. This represents an overall adult smoking prevalence of 14.1%, with higher prevalence among men (17.1%) than among women (11.1%). In comparison, the overall current smoking prevalence was 12.3% in 2022. The adult daily smoking prevalence was recorded to be 10.01% in 2020. Smoking-related mortality also remains significant in the country. In 2021, smoking resulted in 360,370 deaths, including 216,986 male deaths and 143,383 female deaths. This shows that smoking accounted for 10.38% of all deaths in the United States in 2021, with a higher rate among men (11.9%) than among women (8.7%).
Read articles from United States of America
September 14, 2026 by washingtonexaminer.com
Trump’s FDA followed the science on vaping. Politicians are furious
FDA e-cigarette authorisation should be a scientific process, not a political obstacle course. Adult smokers need legal products assessed on evidence, exposure and their potential to reduce harm compared with continued smoking. A system that delays or rejects lower-risk options while cigarettes remain widely available sends the wrong signal. Regulation should protect consumers without allowing politics to decide which routes away from combustion survive.
September 14, 2026 by github.io
How Australia has Lost Control of the Nicotine Market?
Australia’s nicotine policy has become a case study in disinformation with real-world consequences. Smokers are told to quit, yet lower-risk alternatives are restricted, misrepresented or pushed into channels with less oversight. That confusion protects cigarettes more than it protects public health. Evidence-based communication should explain relative risk clearly, support adult switching and stop treating harm reduction as a threat to tobacco control.
September 14, 2026 by substack.com
Why Is Your Patient Still Smoking Cigarettes?
A patient who still smokes is not a failure of character. It may be a sign that the advice, tools or assumptions around quitting are not meeting the reality of dependence. Clinicians can make a difference by asking what has already been tried, what keeps the cigarette in place, and whether lower-risk nicotine options could support a move away from combustion. Smoking cessation works better when care starts with the person, not the expectation that one method should work for everyone.
September 14, 2026 by substack.com
Why Is Your Patient Still Smoking Cigarettes?
A patient who still smokes is not a failure of character. It may be a sign that the advice, tools or assumptions around quitting are not meeting the reality of dependence. Clinicians can make a difference by asking what has already been tried, what keeps the cigarette in place, and whether lower-risk nicotine options could support a move away from combustion. Smoking cessation works better when care starts with the person, not the expectation that one method should work for everyone.
September 11, 2026 by vapingpost.com
Some Sense at Last? Coalition Proposes 80% Tobacco Tax Cut and Legal Vapes to Break Australia’s Black Market
In line with what tobacco harm reduction experts have been suggesting all along, Australia’s opposition party wants to slash tobacco taxes and legalise regulated vapes and nicotine pouches to undermine the country’s booming black market.
September 10, 2026 by tobaccoreporter.com
FDA Names Koplow as Tobacco Center Director
The U.S. Food and Drug Administration has selected Bret Koplow, Ph.D., J.D., as director of the Center for Tobacco Products, giving the center a permanent leader with more than a decade of legal, policy, and regulatory experience at the agency. Koplow has served at FDA since 2011, including as senior counselor to the FDA commissioner, where he focused on regulatory, policy, and operational matters involving tobacco products.
September 10, 2026 by 2firsts.com
GSTHR Estimates 200 Million People Use Non-Combustible Nicotine Products as 28 Countries Show Rising Use Alongside Falling Smoking Rates
GSTHR estimates about 200 million people worldwide use what it terms “safer nicotine products,” including vapes, heated tobacco, nicotine pouches and snus. The report says use of non-combustible products rose while smoking rates fell in 28 countries analyzed.
September 10, 2026 by regulatorwatch.com
Yes, It Is a War | Health Economist Rebukes FDA’s Campaign Against Vaping | RegWatch
The language around vaping has become a policy tool in itself. Describe a product mainly through fear, and the public may never hear the more important comparison: continued smoking versus switching away from combustion. A health economist’s criticism of the FDA campaign highlights the cost of messaging that treats caution as neutrality. Public health should inform smokers clearly, not make lower-risk choices sound too dangerous to consider.
September 09, 2026 by substack.com
When Nicotine Is Treated as Synonymous with Smoking, Science—and People—Lose
Equating nicotine with smoking is one of the most damaging shortcuts in public health communication. Nicotine can cause dependence, but the major burden of disease comes from inhaling smoke from combustible tobacco. Blurring that distinction leaves smokers confused about safer alternatives and less able to judge their options realistically. Clearer policy should target the harms of combustion while giving adults honest information about lower-risk nicotine products.
September 04, 2026 by github.io
SRNT Recommendations to US Physicians on Nicotine E-Cigarettes
Clinical guidance on e-cigarettes is moving from avoidance towards structured, evidence-informed advice. The SRNT recommendations recognise that adult smokers are already asking clinicians about vaping, and that many need options beyond traditional cessation tools. That shift matters because shared decision-making requires more than caution; it requires clear comparisons between continued smoking, complete switching and nicotine abstinence. Harm reduction belongs in the clinical conversation when it helps patients move away from combustion.
- Page 1 of 166
RELATED VIDEOS
RELATED VIDEOS
12 June 2020
2. Greg Conley | USA | - Powerful forces not always benign
24 July 2024
US Cigarette Market is declining!
06 September 2019
USA regulation of ENDS
07 November 2023
FDA vs FLAVOURS | Will Godfrey explores the battle over flavours in the USA | #GFNNews
09 January 2026
AMERICA'S WAR ON SAFER NICOTINE
06 October 2025
VAPING ER “SURGE”: What The Data Really Shows? | GFN News
29 June 2017
Legal remedies in the US - Challenging the FDA. Patricia Kovacevic
18 October 2024
NICOTINE POUCHES UNDER THREAT | Maria Papaioannoy joins us for part 2 of our Canada special